Skip to main content

Table 1 Detailed demographic and clinical information of the enrolled 18 MuSK-MG patients

From: Clinical features, treatment and prognosis of MuSK antibody-associated myasthenia gravis in Northwest China: a single-centre retrospective cohort study

Patient No.

Gender

Onset age (y)

Disease duration (m)

Onset symptoms

Pyridostigmine test

MuSK-ab at diagnosis (nmol/L)

RNS test

Thymic abnormalities on chest CT

Comobidities

Musculus deltoideus

Trapezius

Orbicular oculi

Abductor digiti minimi

1

F

25

58

3

+

1.21

+

+

2

F

25

47

3

+

1.10

+

+

+

+

Hypothyroidism, thyroid cancer

3

F

69

70

1,2,3

0.66

+

+

Hypertension, DM

4

F

46

42

1

+

1.20

+

+

5

F

49

39

1,2

+

1.17

+

Hypothyroidism

6

M

17

25

1

+

1.08

+

+

7

F

16

18

2

0.51

+

+

+

8

F

45

9

1,2

0.66

+

+

9

F

37

196

1,2

+

1.73

+

+

10

F

49

10

1,2,3

0.63

+

+

Hypertension

11

F

27

39

3

+

1.10

+

+

+

12

F

36

44

1,2

+

0.57

+

+

+

+

Hypothyroidism

13

F

28

27

2,3

0.77

+

14

M

28

16

2

0.48

+

+

+

15

F

44

18

3

0.51

+

+

+

16

F

31

24

1

+

0.34

+

+

+

+

17

M

76

34

1,2

+

12.64

18

F

77

1

1

+

0.60

+

Coronary heart disease, lung nodules, DM

  1. Abbreviations: MuSK-ab Muscle-specific kinase antibody, RNS Repetitive nerve stimulation, CT Computed tomography, DM Diabetes mellitus, 1 Ptosis and/or diplopia, 2 Bulbar symptoms, 3 Limbs symptoms, No. Number, F Female, M Male, y Year, m Month; +, positive; −, negative